A Model for NAD(P)H: Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy
NQO1 (NAD(P)H:quinoneoxidoreductase 1) is a reductive enzyme that is an important activator of bioreductive antitumor agents. NQO1 activity varies in individual tumors but is generally higher in tumor cells than in normal cells. NQO1 has been used as a target for tumor specific drug development. We...
Main Authors: | Asher Begleiter, Nadia El-Gabalawy, Laurie Lange, Marsha K. Leith, Lynn J. Guziec, Frank S. Guziec |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2009-01-01
|
Series: | Drug Target Insights |
Online Access: | https://doi.org/10.4137/DTI.S1146 |
Similar Items
-
Update of the NAD(P)H:quinone oxidoreductase (<it>NQO</it>) gene family
by: Vasiliou Vasilis, et al.
Published: (2006-03-01) -
NQO1 binds and supports SIRT1 function
by: Tsvetkov, Peter, et al.
Published: (2021) -
Aerobic Cytotoxicity of Aromatic <i>N-</i>Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1)
by: Aušra Nemeikaitė-Čėnienė, et al.
Published: (2020-11-01) -
Methylmercury (MeHg) transcriptionally regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) in Hepa-1c1c7 cells
by: Mohammed A. Alqahtani, et al.
Published: (2023-01-01) -
Antioxidative enzyme NAD(P)H quinone oxidoreductase 1 (NQO1) modulates the differentiation of Th17 cells by regulating ROS levels.
by: Kyoko Nishida-Tamehiro, et al.
Published: (2022-01-01)